Kineta Enters Merger Agreement with TuHURA Biosciences
Deal News | Dec 18, 2024 | Orrick
TuHURA Biosciences, a Phase 3 registration-stage immuno-oncology company, has signed an agreement to acquire Kineta, a clinical-stage biotechnology company focused on next-generation immunotherapies for oncology. This acquisition includes the rights to Kineta's leading immuno-oncology pipeline asset, KVA12123, a novel VISTA blocking immunotherapy currently in a Phase 1/2 clinical trial. The deal consists of a mix of cash and shares of TuHURA common stock. The merger is expected to enhance shareholder value and advance the development of KVA12123. In addition, Kineta is seeking partnerships for its other technologies unrelated to KVA12123 while continuing the merger process. Orrick served as the legal advisor for Kineta in this transaction.
Sectors
- Biotechnology
- Pharmaceuticals
- Healthcare
Geography
- United States – Both Kineta and TuHURA Biosciences are based in the United States, which is a major hub for biotechnology and pharmaceutical innovation.
Industry
- Biotechnology – The article discusses companies involved in developing next-generation immunotherapies for cancer treatment, a key aspect of the biotechnology industry.
- Pharmaceuticals – Both companies are involved in the development of immuno-oncology drugs, which form a significant part of the pharmaceutical sector.
- Healthcare – The focus on improving cancer treatment aligns the involved parties within the broader healthcare industry.
Financials
- Not Specified – The article mentions a combination of cash and shares of TuHURA common stock but does not specify the exact financial terms.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Kineta, Inc. | Target Company | Company | A clinical-stage biotechnology company developing novel immunotherapies for oncology. |
| TuHURA Biosciences, Inc. | Bidding Company | Company | A Phase 3 registration-stage immuno-oncology company focusing on overcoming cancer immunotherapy resistance. |
| Orrick | Legal Advisor for Kineta | Company | An international law firm serving as the legal advisor for Kineta in the merger with TuHURA. |